OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer
Ganesh Acharya, Chinnadurai Mani, Naresh Sah, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Ganesh Acharya, Chinnadurai Mani, Naresh Sah, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
CHK1 inhibition overcomes gemcitabine resistance in non-small cell lung cancer cell A549
Zhi-Yin Ke, Tian Fu, Xuechun Wang, et al.
Molecular & Cellular Oncology (2025) Vol. 12, Iss. 1
Open Access
Zhi-Yin Ke, Tian Fu, Xuechun Wang, et al.
Molecular & Cellular Oncology (2025) Vol. 12, Iss. 1
Open Access
The Significance of MAPK Signaling Pathway in the Diagnosis and Subtype Classification of Intervertebral Disc Degeneration
Yong Liu, Xueyan Chen, Jingwen Chen, et al.
JOR Spine (2025) Vol. 8, Iss. 1
Open Access
Yong Liu, Xueyan Chen, Jingwen Chen, et al.
JOR Spine (2025) Vol. 8, Iss. 1
Open Access
Emerging strategies to overcome ovarian cancer: advances in immunotherapy
Tatiana Massariol Pimenta, Josiany Carlos de Souza, Bárbara da Silva Martins, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Tatiana Massariol Pimenta, Josiany Carlos de Souza, Bárbara da Silva Martins, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer
Ramya Ravindranathan, Ozge Somuncu, Alexandre André Balieiro Anastácio da Costa, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 47
Closed Access | Times Cited: 1
Ramya Ravindranathan, Ozge Somuncu, Alexandre André Balieiro Anastácio da Costa, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 47
Closed Access | Times Cited: 1
Receptor-Based Strategies for Overcoming Resistance in Cancer Therapy
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
LEF1 is associated with immunosuppressive microenvironment of patients with lung adenocarcinoma
Xiaoqing Liu, C.Y. Wang, Xiaoling Zhang, et al.
Medicine (2024) Vol. 103, Iss. 41, pp. e39892-e39892
Open Access
Xiaoqing Liu, C.Y. Wang, Xiaoling Zhang, et al.
Medicine (2024) Vol. 103, Iss. 41, pp. e39892-e39892
Open Access
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents
Rocco Caggiano, Evgeniia Prokhorova, Lena Duma, et al.
Neoplasia (2024) Vol. 59, pp. 101092-101092
Closed Access
Rocco Caggiano, Evgeniia Prokhorova, Lena Duma, et al.
Neoplasia (2024) Vol. 59, pp. 101092-101092
Closed Access
Decoding NAD+ Metabolism in COVID-19: Implications for Immune Modulation and Therapy
Shixu Song, Jianhong Gan, Qiuyue Long, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 1-1
Open Access
Shixu Song, Jianhong Gan, Qiuyue Long, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 1-1
Open Access
